ZapA, a virulence factor in a rat model of Proteus mirabilis-induced acute and chronic prostatitis

Infection and Immunity

Volumn 76, Issue 11, 2008, Pages 4859-4864

  Phan, Van ^a   Belas, Robert ^b   Gilmore, Brendan F ^c   Ceri, Howard ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ZAPA; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CONTROLLED STUDY; IMMUNE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATITIS; PROTEIN FUNCTION; PROTEUS MIRABILIS; RAT;

ANIMALS; BACTERIAL PROTEINS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; MALE; PROSTATITIS; PROTEUS INFECTIONS; PROTEUS MIRABILIS; RATS; RATS, SPRAGUE-DAWLEY; VIRULENCE FACTORS;

EID: 55849135540     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00122-08     Document Type: Article

References (31)

1. Allison, C., H. C. Lai, and C. Hughes. 1992. Co-ordinate expression of virulence genes during swarm-cell differentiation and population migration of Proteus mirabilis. Mol. Microbiol. 6:1583-1591.
2. Bardouniotis, E., H. Ceri, and M. E. Olson. 2003. Biofilm formation and biocide susceptibility testing of Mycobacterium fortuitum and Mycobacterium marinum. Cur. Microbiol. 46:28-32.
3. Belas, R., J. Manos, and R. Suvanasuthi. 2004. Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect. Immun. 72:5159-5167.
4. Belas, R., and R. Suvanasuthi. 2005. The ability of Proteus mirabilis to sense surfaces and regulate virulence gene expression involves FilL, a flagellar basal body protein. J. Bacteriol. 187:6789-6803.
5. Ceri, H., M. E. Olson, and J. C. Nickel. 1999. Prostatitis: role of the animal model, p. 109-114. In J. C. Nickel (ed.), Textbook of prostatitis. Isis Medical Media, Oxford, United Kingdom.
6. Ceri, H., M. E. Olson, C. Stremick, R. R. Read, D. Morck, and A. Buret. 1999. The Calgary biofilm device: a new technology for the rapid determination of antibiotic susceptibility of bacterial biofilms. J. Clin. Microbiol. 37:1771-1776.
7. Ceri, H., S, Schmidt, M. E. Olson, J. C. Nickel, and H. Benedikisson. 1999. Specific mucosal immunity in the pathophysiology of bacterial prostatitis in a rat model. Can. J. Microbiol. 45:849-855.
8. Gionchetti, P., M. Campieri, A. Belluzzi, E. Bertinelli, M. Ferretti, C. Brignola, G. Poggioli, M. Miglioli, and L. Barbara. 1994. Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8. and tumor necrosis factor-α in pelvic ileal pouches. Dig. Dis. Sci. 39:1525-1531.
9. Harrison, J. J., M. Rabiei, R. J. Turner, E. A. Badry, K. M. Sproule, and H. Ceri. 2006. Metal resistance in Candida biofilms. FEMS Microb. Ecol. 55:479-491.
10. Harrison, J. J., R. J. Turner, L. R. Marques, and H. Ceri. 2005. Biofilms: a new understanding of these microbial communities is driving a revolution that may transform the science of microbiology. Am. Sci. 93:508-515.
11. Jahnukainen, T., M. Chen, and G. Celsi. 2005. Mechanisms of renal damage owing to infection. Pediatr. Nephrol. 20:1043-1053.
12. Jones, S. M., J. Yerly, Y. Hu, H. Ceri, and R. Martinuzzi. 2007. Structure of Proteus mirabilis biofilms grown in artificial urine and standard laboratory media. FEMS Microbiol. Lett. 268:16-21.
13. Lang, M. D., J. C. Nickel, M. E. Olson, S. R. Howard, and H. Ceri. 2000. Rat model of experimentally induced abacterial prostatitis. Prostate 45:201-206.
14. Marrs, C. F., L. Zhang, and B. Foxman. 2005. Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes? FEMS Microbiol. Lett. 252:183-190.
15. Mitsumori, K. A., A. Terai, S. Yamamoto, S. Ishitoya, and O. Yoshida. 1999. Virulence characteristics of Escherichia coli in acute bacterial prostatitis. J. Infect. Dis. 180:1378-1381.
16. Mobley, H., and R. Belas. 1995. Swarming and pathogenicity of Proteus mirabilis in the urinary tract. Trends Microbiol. 3:280-284.
17. Mullane, K. M., R. Kraemer, and B. Smith. 1985. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods 14:157-167.
18. Nickel, J. C. 2006. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis. Curr. Opin. Urol. 16:5-10.
19. Nickel, J. C., M. E. Olson, A. Barabas, H. Benedikisson, K. Dasgupta, and J. W. Costerton. 1990. Pathogenesis of chronic bacterial prostatitis in an animal model. Br. J. Urol. 66:47-54.
20. Nickel, J. C., and T. Moon. 2005. Chronic bacterial prostatitis: an evolving clinical enigma. Urology 66:2-8.
21. Olson, M. E., H. Ceri, D. W. Morck, A. G. Buret, and R. R. Read. 2002. Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can. J. Vet. Res. 66:86-92.
22. Rippere-Lampe, K. E., M. D. Lang, H. Ceri, M. Olson, H. A. Lockman, and A. D. O'Brien. 2001. Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model. Infect. Immun. 69:6515-6519.
23. Rippere-Lampe, K. E., A. D. O'Brien, R. Conran, and A. D. Lockman. 2001. Mutations of the gene encoding cytotoxic necrotizing type 1 (cnf1) attenuates the virulence of uropathogenic Escherichia coli. Infect. Immun. 69:3954-3964.
24. Senior, B. W. 1983. Proteus morgani is less frequently associated with urinary tract infections than Proteus mirabilis - an explanation. J. Med. Microbiol. 16:317-322.
25. Terai, A., S. Ishitoya, K. Mitsumori, and O. Ogawa. 2000. Molecular epidemiological evidence for ascending urethral infection in acute bacterial prostatitis. J. Urol. 164:1945-1947.
26. Walker, K. E., S. Moghaddame-Jafari, C. V. Lockatell, D. Johnson, and R. Belas. 1999. ZapA, the IgA-degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells. Mol. Microbiol. 32:825-836.
27. Wassif, C., D. Cheek, and R. Belas. 1995. Molecular analysis of a metalloprotease from Proteus mirabilis. J. Bacteriol. 177:5790-5798.
28. Wilson, M. J., M. Woodson, C. Wiehr, A. Reddy, and A. A. Sinha. 2004. Matrix metalloproteinasas in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wister rat. Exp. Mol. Pathol. 77:7-17.
29. Xie, J., B. Foxman, L. Zhang, and C. F. Marrs. 2006. Molecular epidemiologic identification of Escherichia coli genes that are potentially involved in movement of organisms from intestinal tract to the vagina and bladder. J. Clin. Microbiol. 44:2434-2441.
30. Yamamoto, S. 2007. Molecular epidemiology of uropathogenic Escherichia coli. J. Infect. Chemother. 13:68-73.
31. Zunino, P., L. Geymonat, A. G. Allen, A. Preston, V. Sosa, and D. J. Maskell. 2001. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infections. FEMS Immunol. Med. Microbiol. 31:113-120.